低风险经产妇妊娠39-41周的新生儿与母体不良结局
与39周相比,40周和41周的新生儿及母体复合不良结局风险均升高。
要点
- 低风险经产妇39周分娩的新生儿复合不良结局风险最低。
- 与39周相比,40周和41周分娩的新生儿复合不良结局风险均升高。
- 与39周相比,40周和41周分娩的母体复合不良结局风险均升高。
核心结论
- 在低风险经产妇中,从39周至41周,新生儿和母体复合不良结局的发生率虽仅轻度但确实升高。
主要发现
- 新生儿复合不良结局总体发生率为4.86/1000活产;与39周相比,40周aRR 1.18(95%CI 1.15-1.22),41周aRR 1.59(95%CI 1.53-1.65)。
- 母体复合不良结局总体发生率为2.31/1000活产;与39周相比,40周aRR 1.15(95%CI 1.11-1.19),41周aRR 1.50(95%CI 1.42-1.58)。
- 分娩孕周分布:39周54.4%,40周35.7%,41周9.9%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the composite neonatal or maternal adverse outcome among low-risk, parous women at 39-41 weeks of gestation. METHODS: This was a retrospective cohort study using the U.S. vital statistics data sets (2012-2016). We evaluated low-risk parous women with nonanomalous singleton gestations who delivered at 39, 40, or 41 weeks of gestation (as reported in completed weeks, eg, 39 weeks includes 39 0/7-39 6/7 weeks of gestation). The primary outcome, the composite neonatal adverse outcome, included any of the following: Apgar score less than 5 at 5 minutes, assisted ventilation for longer than 6 hours, neonatal seizure, or neonatal mortality. The secondary outcome, the composite maternal adverse outcome, included any of the following: intensive care unit admission, blood transfusion, uterine rupture, or unplanned hysterectomy. We used multivariable Poisson regression analyses to estimate the association between gestational age and adverse outcome (using adjusted relative risks [aRR] and 95% CI). RESULTS: Of 19.9 million live births during the study period, 5.4 million (27.1%) met inclusion criteria. Among them, 54.4% delivered at 39 weeks of gestation, 35.7% at 40 weeks, and 9.9% at 41 weeks. The overall rate of the composite neonatal adverse outcome was 4.86 per 1,000 live births. The risk of the composite neonatal adverse outcome was higher for those delivered at 40 (aRR 1.18; 95% CI 1.15-1.22) and 41 (aRR 1.59; 95% CI 1.53-1.65) weeks of gestation when compared with 39 weeks. The overall rate of the composite maternal adverse outcome was 2.31 per 1,000 live births. The risk of the composite maternal adverse outcome was also significantly higher with delivery at 40 (aRR 1.15; 95% CI 1.11-1.19) and 41 weeks of gestation (aRR 1.50; 95% CI 1.42-1.58) than at 39 weeks. CONCLUSION: Though only modestly, the rates of the composite neonatal and maternal adverse outcomes increase, from 39 through 41 weeks of gestation, among low-risk parous women.
引用
- Chen HY, Grobman WA, Blackwell SC, et al. Neonatal and Maternal Adverse Outcomes Among Low-Risk Parous Women at 39-41 Weeks of Gestation. Obstet Gynecol. 2019. PMID: 31306312. doi:10.1097/AOG.0000000000003372
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。